Barclays PLC Reduces Holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL)
MarketBeat
Barclays PLC lessened its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 35.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 331,242 shares of the biopharmaceutical company's stock after selling 180,280 s
NASDAQ:OCUL